Close Menu
Home » FDA Expands Label for Roche Cobas EGFR Companion Diagnostic

FDA Expands Label for Roche Cobas EGFR Companion Diagnostic

Sep 29, 2016
|
staff reporter

NEW YORK (GenomeWeb) – The US Food and Drug Administration has expanded the labeling for Roche's Cobas EGFR Mutation Test v2 as a companion diagnostic that can analyze plasma samples from non-small cell lung cancer patients considering treatment with AstraZeneca's Tagrisso (osimertinib). 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

From All Corners of the World

Researchers are sampling the wild relatives of modern crops to try to preserve genetic diversity, NPR reports.

Might as Well Look

MIT's Search for Extraterrestrial Genomes is developing sequencing tools to use to try to detect whether there is any life on Mars, Quartz reports.

Bill for Science Integrity

Undark reports on a bill introduced this year to the US House of Representatives to strengthen scientific integrity.

Genome Research Papers Focus on Gene Functions, Aging Transcriptomic, Diabetes Models

In Genome Research this week: post-zygotic mutations in diabetes development, single-cell RNA sequencing study of aging, and more.

Dec
11
Featured Webinar

Advances in Precision Oncology: Tertiary Analysis Software for Solid Tumor NGS

Sponsored by
Roche

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  2. Ambry Genetics, Caris Life Sciences Partner on Cancer Genetic Testing

  3. NCCN Updates Genetic Testing Guidelines for Assessing Breast, Ovarian, Pancreatic Cancer Risk

  4. FDA Approves Foundation Medicine CDx for Novartis Breast Cancer Drug Piqray

  5. Veracyte Exclusively Licenses NanoString Diagnostic Platform for Up to $60M

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.